Pathstone Family Office’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-59
Closed -$7K 982
2019
Q1
$7K Hold
59
﹤0.01% 561
2018
Q4
$2K Buy
+59
New +$2K ﹤0.01% 491